Application of New French Guidelines for Economic Evaluations- A Cost-Effectiveness Analysis of Apixaban in Patients with Non-Valvular Atrial Fibrillation in France
Abstract
Authors
I. Durand-Zaleski F.E. Cotté T. Lanitis C. Godard I. Kachaner T. Kongnakorn A.F. Gaudin